BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response

Major problems of current antidepressant pharmacotherapy are insufficient response rates and difficulties in response prediction. We recently provided preliminary evidence in a small study that patients with major depressive disorder (MDD) with a hypomethylation of the CpG-87 site of the promoter IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Lieb, Klaus, Dreimüller, Nadine, Wagner, Stefanie, Schlicht, Konrad, Falter, Tanja, Neyazi, Alexandra, Müller-Engling, Linda, Bleich, Stefan, Tadić, André, Frieling, Helge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232909/
https://www.ncbi.nlm.nih.gov/pubmed/30459647
http://dx.doi.org/10.3389/fpsyt.2018.00511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232909/
https://www.ncbi.nlm.nih.gov/pubmed/30459647
http://dx.doi.org/10.3389/fpsyt.2018.00511

Ejemplares similares